Dexcom, headquartered in San Diego, California, is a leading medical technology company that specializes in continuous glucose monitoring (CGM) systems. It was founded in 1999 by a group of engineers who sought to create innovative solutions for people with diabetes. The company's flagship product is the Dexcom G6, a CGM system that allows individuals with diabetes to monitor their blood glucose levels continuously, providing real-time data without the need for traditional fingerstick testing.

The G6 system consists of a small sensor worn on the body, along with a transmitter that sends the data wirelessly to a compatible display device, such as a smartphone or insulin pump. Dexcom operates on a global scale, with subsidiaries and distribution partnerships in various countries worldwide. Notably, the company has partnered with Verily, an Alphabet (Google) company, to develop next-generation CGM systems and integrated diabetes management solutions.

In terms of market position, Dexcom is widely recognized as a leader in the CGM industry. The company has experienced significant growth in recent years, with global sales reaching over $1 billion in 2020. Dexcom's primary competitors include Medtronic and Abbott, but Dexcom is known for its superior accuracy, ease of use, and advanced features, which have contributed to its strong market presence.

Dexcom has achieved several milestones and received numerous awards for its innovative products. In 2018, the Dexcom G6 became the first CGM system to receive FDA approval allowing it to make treatment decisions without a confirmatory fingerstick. This advancement significantly improved the convenience and quality of care for people with diabetes.

As of the latest information available, Dexcom continues to innovate and expand its product lineup. The company recently released the Dexcom G7, a smaller and more discreet CGM system expected to improve user experience and reach a larger customer base. Dexcom's commitment to continuous improvement and dedication to empowering individuals with diabetes has solidified its position as a leader in the CGM industry.

In conclusion, Dexcom is a prominent medical technology company that has been at the forefront of continuous glucose monitoring systems for people with diabetes. With its innovative products, strong market position, and commitment to advancing diabetes care, Dexcom remains a key player in the global healthcare industry